JP2002526499A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526499A5
JP2002526499A5 JP2000574109A JP2000574109A JP2002526499A5 JP 2002526499 A5 JP2002526499 A5 JP 2002526499A5 JP 2000574109 A JP2000574109 A JP 2000574109A JP 2000574109 A JP2000574109 A JP 2000574109A JP 2002526499 A5 JP2002526499 A5 JP 2002526499A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000574109A
Other languages
Japanese (ja)
Other versions
JP4145492B2 (ja
JP2002526499A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1999/006899 external-priority patent/WO2000017200A1/en
Publication of JP2002526499A publication Critical patent/JP2002526499A/ja
Publication of JP2002526499A5 publication Critical patent/JP2002526499A5/ja
Application granted granted Critical
Publication of JP4145492B2 publication Critical patent/JP4145492B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000574109A 1998-09-23 1999-09-17 テトラヒドロピリドエーテル Expired - Lifetime JP4145492B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP19843504.5 1998-09-23
EP98117988 1998-09-23
EP98117988.0 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (3)

Publication Number Publication Date
JP2002526499A JP2002526499A (ja) 2002-08-20
JP2002526499A5 true JP2002526499A5 (US07585860-20090908-C00150.png) 2005-11-17
JP4145492B2 JP4145492B2 (ja) 2008-09-03

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574109A Expired - Lifetime JP4145492B2 (ja) 1998-09-23 1999-09-17 テトラヒドロピリドエーテル

Country Status (31)

Country Link
US (4) US6436953B1 (US07585860-20090908-C00150.png)
EP (1) EP1115725B1 (US07585860-20090908-C00150.png)
JP (1) JP4145492B2 (US07585860-20090908-C00150.png)
KR (1) KR100668400B1 (US07585860-20090908-C00150.png)
CN (2) CN100506821C (US07585860-20090908-C00150.png)
AT (1) ATE231862T1 (US07585860-20090908-C00150.png)
AU (1) AU763463B2 (US07585860-20090908-C00150.png)
BG (1) BG65195B1 (US07585860-20090908-C00150.png)
BR (1) BR9914044A (US07585860-20090908-C00150.png)
CA (1) CA2344251A1 (US07585860-20090908-C00150.png)
CZ (1) CZ292335B6 (US07585860-20090908-C00150.png)
DE (1) DE69905178T2 (US07585860-20090908-C00150.png)
DK (1) DK1115725T3 (US07585860-20090908-C00150.png)
EA (1) EA005377B1 (US07585860-20090908-C00150.png)
EE (1) EE04677B1 (US07585860-20090908-C00150.png)
ES (1) ES2191464T3 (US07585860-20090908-C00150.png)
GE (1) GEP20032926B (US07585860-20090908-C00150.png)
HK (1) HK1038360B (US07585860-20090908-C00150.png)
HR (1) HRP20010224A2 (US07585860-20090908-C00150.png)
HU (1) HUP0102990A3 (US07585860-20090908-C00150.png)
ID (1) ID28896A (US07585860-20090908-C00150.png)
IL (2) IL142063A0 (US07585860-20090908-C00150.png)
NO (1) NO317304B1 (US07585860-20090908-C00150.png)
NZ (1) NZ510610A (US07585860-20090908-C00150.png)
PL (1) PL193616B1 (US07585860-20090908-C00150.png)
PT (1) PT1115725E (US07585860-20090908-C00150.png)
RS (1) RS50145B (US07585860-20090908-C00150.png)
SI (1) SI1115725T1 (US07585860-20090908-C00150.png)
SK (1) SK285165B6 (US07585860-20090908-C00150.png)
TR (1) TR200100805T2 (US07585860-20090908-C00150.png)
WO (1) WO2000017200A1 (US07585860-20090908-C00150.png)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005377B1 (ru) 1998-09-23 2005-02-24 Алтана Фарма Аг ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ
PT1173439E (pt) 1999-04-17 2003-10-31 Altana Pharma Ag Haloalcoxi imidazonaftiridinas
CA2721484A1 (en) * 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
CN1221553C (zh) * 2000-03-29 2005-10-05 奥坦纳医药公司 三环咪唑并吡啶类化合物及药物组合物
IL151200A0 (en) * 2000-03-29 2003-04-10 Altana Pharma Ag Tricyclic imidazopyridine prodrug derivatives and pharmaceutical compositions containing the same
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
JP2004520422A (ja) * 2001-03-08 2004-07-08 アストラゼネカ・アクチエボラーグ 新しい用途
HUP0400379A3 (en) 2001-08-02 2007-10-29 Altana Pharma Ag Tricyclic epoxides and their use for the preparation of pharmaceutically active agents
HUP0400380A3 (en) * 2001-08-03 2007-05-29 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders and pharmaceuticals containing them
US20040235882A1 (en) * 2001-08-03 2004-11-25 Jorg Senn-Bilfinger Amino-substituted imidazopyridines for the treatment of gastrointestial diseases
EA008375B1 (ru) 2002-02-15 2007-04-27 Алтана Фарма Аг Трициклические n-ацильные соединения
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EA200401454A1 (ru) * 2002-05-07 2005-06-30 Алтана Фарма Аг Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
AU2003288071A1 (en) 2002-11-19 2004-06-15 Altana Pharma Ag 8-substituted imidazopyridines
US7879833B2 (en) 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
AU2003293940A1 (en) * 2002-12-20 2004-07-14 Altana Pharma Ag 8-trialkysyloxy-2-methyl-9-phenyl-7-0 XO-7,8,9,10- tetrahydroimidazo '1,2-H! '1,7! naphthyridines
EP1599175A2 (en) * 2003-02-17 2005-11-30 ALTANA Pharma AG Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
MXPA05012463A (es) * 2003-05-27 2006-01-30 Altana Pharma Ag Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
AU2004268641A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
US7326784B2 (en) 2003-12-19 2008-02-05 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
WO2006025714A1 (en) 2004-09-03 2006-03-09 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
AU2005290360B2 (en) 2004-09-03 2011-06-30 Yuhan Corporation Pyrrolo(3,2-b)pyridine derivatives and processes for the preparation thereof
BRPI0514925A (pt) 2004-09-03 2008-07-01 Yuhan Corp derivados de pirrol[2,3-c]piridina e processos para a preparação destes
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
WO2011004882A1 (ja) * 2009-07-09 2011-01-13 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
WO2013187727A1 (en) * 2012-06-15 2013-12-19 Bio-Pharm Solutions Co., Ltd. Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
EP3054949A1 (en) 2013-10-08 2016-08-17 Katairo GmbH Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
PT87988B (pt) 1987-07-16 1995-05-04 Byk Gulden Lomberg Chem Fab Processo para a preparacao de diazois e de composicoes farmaceuticas que os contem
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
CA2196076A1 (en) * 1994-07-28 1996-02-08 Gerhard Grundler Acyl imidazopyridines
US6197783B1 (en) * 1997-03-24 2001-03-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
EP0971922B1 (en) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyrido compounds
EA005377B1 (ru) * 1998-09-23 2005-02-24 Алтана Фарма Аг ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ

Similar Documents

Publication Publication Date Title
BE2018C020I2 (US07585860-20090908-C00150.png)
BE2016C007I2 (US07585860-20090908-C00150.png)
BE2015C057I2 (US07585860-20090908-C00150.png)
BE2015C018I2 (US07585860-20090908-C00150.png)
BE2014C017I2 (US07585860-20090908-C00150.png)
BE2013C051I2 (US07585860-20090908-C00150.png)
BE2013C020I2 (US07585860-20090908-C00150.png)
BE2013C015I2 (US07585860-20090908-C00150.png)
BE2013C001I2 (US07585860-20090908-C00150.png)
BE2012C036I2 (US07585860-20090908-C00150.png)
BE2011C004I2 (US07585860-20090908-C00150.png)
BE2010C011I2 (US07585860-20090908-C00150.png)
BE2008C046I2 (US07585860-20090908-C00150.png)
BE1025464I2 (US07585860-20090908-C00150.png)
BRPI0017527B8 (US07585860-20090908-C00150.png)
JP2002500922A5 (US07585860-20090908-C00150.png)
JP2002518111A5 (US07585860-20090908-C00150.png)
BE2008C047I2 (US07585860-20090908-C00150.png)
BRPI0001672A2 (US07585860-20090908-C00150.png)
JP2002507572A5 (US07585860-20090908-C00150.png)
JP2002526499A5 (US07585860-20090908-C00150.png)
BRPI0001542A2 (US07585860-20090908-C00150.png)
BRPI0012675B8 (US07585860-20090908-C00150.png)
BRPI0017522A2 (US07585860-20090908-C00150.png)
BRMU7902607U2 (US07585860-20090908-C00150.png)